SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-18-001273
Accepted
2018-05-17 00:15:15
Documents
1
Effectiveness Date
2018-05-16
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 605
  Complete submission text file 9999999995-18-001273.txt   1813
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-224586 | Film No.: 18841630
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1